Charles River Laboratories International Management
Management criteria checks 3/4
Charles River Laboratories International's CEO is Jim Foster, appointed in Jan 1991, has a tenure of 33.92 years. total yearly compensation is $14.10M, comprised of 10.4% salary and 89.6% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $43.07M. The average tenure of the management team and the board of directors is 5.1 years and 7.4 years respectively.
Key information
Jim Foster
Chief executive officer
US$14.1m
Total compensation
| CEO salary percentage | 10.4% |
| CEO tenure | 33.9yrs |
| CEO ownership | 0.5% |
| Management average tenure | 5.1yrs |
| Board average tenure | 7.4yrs |
Recent management updates
Recent updates
Is There Now An Opportunity In Charles River Laboratories International, Inc. (NYSE:CRL)?
Dec 11
Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
Nov 19Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You
Oct 11Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Charles River Laboratories: Very Attractive After The Pullback
Jul 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 28 2024 | n/a | n/a | US$413m |
| Jun 29 2024 | n/a | n/a | US$432m |
| Mar 30 2024 | n/a | n/a | US$439m |
| Dec 30 2023 | n/a | n/a | US$475m |
| Sep 30 2023 | n/a | n/a | US$475m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$496m |
| Dec 31 2022 | US$13m | US$1m | US$486m |
| Sep 24 2022 | n/a | n/a | US$436m |
| Jun 25 2022 | n/a | n/a | US$443m |
| Mar 26 2022 | n/a | n/a | US$422m |
| Dec 25 2021 | US$14m | US$1m | US$391m |
| Sep 25 2021 | n/a | n/a | US$397m |
| Jun 26 2021 | n/a | n/a | US$396m |
| Mar 27 2021 | n/a | n/a | US$375m |
| Dec 26 2020 | US$13m | US$1m | US$364m |
| Sep 26 2020 | n/a | n/a | US$301m |
| Jun 27 2020 | n/a | n/a | US$271m |
| Mar 28 2020 | n/a | n/a | US$248m |
| Dec 28 2019 | US$18m | US$1m | US$252m |
| Sep 28 2019 | n/a | n/a | US$231m |
| Jun 29 2019 | n/a | n/a | US$219m |
| Mar 30 2019 | n/a | n/a | US$227m |
| Dec 29 2018 | US$14m | US$1m | US$225m |
| Sep 29 2018 | n/a | n/a | US$135m |
| Jun 30 2018 | n/a | n/a | US$128m |
| Mar 31 2018 | n/a | n/a | US$129m |
| Dec 30 2017 | US$13m | US$1m | US$123m |
Compensation vs Market: Jim's total compensation ($USD14.10M) is above average for companies of similar size in the US market ($USD8.04M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Foster (73 yo)
33.9yrs
Tenure
US$14,096,923
Compensation
Mr. James C. Foster, J.D. has been the Chairman of the Board at Charles River Laboratories, Inc. (CRL) since 2000 and has been its Chief Executive Officer since 1992 and serves as its President since 1991....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | 33.9yrs | US$14.10m | 0.45% $ 43.1m | |
| Corporate Executive VP & CFO | 2.6yrs | US$3.81m | 0.0049% $ 469.3k | |
| Corporate Executive VP & COO | 3.1yrs | US$4.99m | 0.083% $ 7.9m | |
| Corporate Executive Vice President of Corporate Development & Strategy | 13.9yrs | US$3.06m | 0.021% $ 2.0m | |
| Corporate Executive Vice President of Community Relations | 8.2yrs | US$2.91m | 0.050% $ 4.8m | |
| Corporate Senior VP & Chief Accounting Officer | 7.7yrs | no data | 0.010% $ 988.0k | |
| Corporate Senior VP & Chief Scientific Officer | 3.1yrs | no data | no data | |
| Corporate Senior VP & Chief Information Officer | 3.5yrs | no data | no data | |
| Corporate Vice President of Investor Relations | no data | no data | no data | |
| Corporate Senior VP | 4.3yrs | no data | no data | |
| Corporate Vice President & Chief Communications Officer | no data | no data | no data | |
| Corporate Executive VP & Chief People Officer | 5.9yrs | no data | 0.020% $ 1.9m |
5.1yrs
Average Tenure
54yo
Average Age
Experienced Management: CRL's management team is seasoned and experienced (5.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | 35.9yrs | US$14.10m | 0.45% $ 43.1m | |
| Independent Director | 13.9yrs | US$339.77k | 0.022% $ 2.1m | |
| Lead Independent Director | 21.9yrs | US$371.02k | 0.010% $ 984.2k | |
| Independent Director | 5.2yrs | US$346.02k | 0.0067% $ 632.7k | |
| Independent Director | 13.9yrs | US$346.02k | 0.062% $ 5.9m | |
| Independent Director | 2yrs | US$437.78k | 0.0018% $ 169.1k | |
| Director | 7.4yrs | US$336.02k | 0.023% $ 2.2m | |
| Independent Director | 16.2yrs | US$339.77k | 0.014% $ 1.4m | |
| Independent Director | 4.8yrs | US$339.77k | 0.0048% $ 456.9k | |
| Independent Director | 4.2yrs | US$324.77k | 0.0049% $ 461.7k | |
| Independent Director | less than a year | no data | 0.00033% $ 31.3k |
7.4yrs
Average Tenure
68yo
Average Age
Experienced Board: CRL's board of directors are considered experienced (7.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:49 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Charles River Laboratories International, Inc. is covered by 45 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Gregory Bolan | Avondale Partners |
| Eric Coldwell | Baird |